NCT07449520
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗
- Notable Recruitment opened
- Eligibility criteria expanded, about 18 words
- Study sites: 10 to 12
- Start date changed from estimate of Mar 2026 to Mar 17, 2026
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
Total Body Weight Loss
Timeframe: At the inclusion and 24 months after procedure
Secondary (6)
Excess weight loss
Body Mass Index (BMI)
Adverse events
Comorbidities improvement
Quality of life improvement
Show 1 moreShow less
Additional treatments
Arms and interventions
All adult patients with obesity scheduled for endoscopic gastroplasty (ESG)
Procedures: Endoscopic sleeve gastroplasty
Sites
12 sites in 2 countries
France 11, Guadeloupe 1